Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8A1R

cryo-EM structure of thioredoxin glutathione reductase in complex with a non-competitive inhibitor

Summary for 8A1R
Entry DOI10.2210/pdb8a1r/pdb
EMDB information15084
DescriptorThioredoxin glutathione reductase, FLAVIN-ADENINE DINUCLEOTIDE, (2~{R},3~{R},4~{S},5~{R})-2-[3-[[[(1~{R},2~{R},3~{R},5~{S})-2,6,6-trimethyl-3-bicyclo[3.1.1]heptanyl]amino]methyl]indol-1-yl]oxane-3,4,5-triol (3 entities in total)
Functional Keywordsinhibitor, complex, flavoreductase, flavoprotein
Biological sourceSchistosoma mansoni
Total number of polymer chains2
Total formula weight132522.47
Authors
Ardini, M.,Angelucci, F.,Fata, F.,Gabriele, F.,Effantin, G.,Ling, W.,Williams, D.L.,Petukhova, V.Z.,Petukhov, P.A. (deposition date: 2022-06-01, release date: 2023-06-14, Last modification date: 2024-11-13)
Primary citationPetukhova, V.Z.,Aboagye, S.Y.,Ardini, M.,Lullo, R.P.,Fata, F.,Byrne, M.E.,Gabriele, F.,Martin, L.M.,Harding, L.N.M.,Gone, V.,Dangi, B.,Lantvit, D.D.,Nikolic, D.,Ippoliti, R.,Effantin, G.,Ling, W.L.,Johnson, J.J.,Thatcher, G.R.J.,Angelucci, F.,Williams, D.L.,Petukhov, P.A.
Non-covalent inhibitors of thioredoxin glutathione reductase with schistosomicidal activity in vivo.
Nat Commun, 14:3737-3737, 2023
Cited by
PubMed Abstract: Only praziquantel is available for treating schistosomiasis, a disease affecting more than 200 million people. Praziquantel-resistant worms have been selected for in the lab and low cure rates from mass drug administration programs suggest that resistance is evolving in the field. Thioredoxin glutathione reductase (TGR) is essential for schistosome survival and a validated drug target. TGR inhibitors identified to date are irreversible and/or covalent inhibitors with unacceptable off-target effects. In this work, we identify noncovalent TGR inhibitors with efficacy against schistosome infections in mice, meeting the criteria for lead progression indicated by WHO. Comparisons with previous in vivo studies with praziquantel suggests that these inhibitors outperform the drug of choice for schistosomiasis against juvenile worms.
PubMed: 37349300
DOI: 10.1038/s41467-023-39444-y
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (3.6 Å)
Structure validation

248335

PDB entries from 2026-01-28

PDB statisticsPDBj update infoContact PDBjnumon